Rare diseases
Investigational molecules
Locations
13 Quai Jules Guesde, 94400, France
Clinical research includes ulcerative colitis, Crohn's disease, rheumatoid arthritis, systemic lupus erythematosus, and systemic juvenile idiopathic arthritis, with additional interest in coeliac disease and chronic graft versus host disease.
Research also extends to immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune system diseases.
Sanofi-Aventis Recherche & Developpement runs clinical trials in conditions such as Dermatitis atopic, Chronic obstructive pulmonary disease, Asthma, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
CzechiaStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
BelgiumA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
AustriaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
AustriaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
AustriaTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
BelgiumStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FranceStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
AustriaA study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
BelgiumEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
